Betavive Ltd.
PrivateCompany Overview
Betavive Ltd. is a biotechnology company developing disease-modifying therapies for diabetes by restoring insulin-producing beta cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydiabetes treatmentregenerative medicinepeptide therapeuticsdrug discoverybeta cell regenerationdisease-modifying therapyclinical trialsbiotech startuppreclinical researchtype 1 diabetestype 2 diabetesprecision medicinebiotech R&Dcure for diabetes
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Betavive Ltd. Comparables
Compare Betavive Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiogenX | 86% | |
| Dia Beta Labs Ltd | 84% | |
| Paulex Bio Inc. | 84% | |
Betavive Ltd. Funding Rounds
Historical fundraising activity
Betavive Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Betavive Ltd.'s valuation, stock price, and market status.
See something wrong or outdated?